ZOMDF
Zomedica Corp.Company with tickers: ZOMDF
CIK
1684144
CUSIP
98980M109
Shares Outstanding
979,949,668
13F Activity (30d)
2 filings
2 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $8,799,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | $3,315,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Gross Profit | $5,484,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Expenses | — | ||||
| Research & Development | $1,154,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $-4,900,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $-4,534,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Segment (USD)
| Component | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Therapeutics | $24,852,000 | $26,197,000 |
| Development Services | — | $3,032,000 |
| Diagnostics | $2,433,000 | $2,801,000 |
By Geography (USD)
| Component | 2024-12-31 | 2025-12-31 |
|---|---|---|
| United States | $22,556,000 | $26,461,000 |
| Non Us | $4,729,000 | $5,569,000 |
By Product & Service (USD)
| Component | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Consumables Revenue | $17,663,000 | $20,678,000 |
| Capital Revenue | $9,491,000 | $9,253,000 |
| Engineering Revenue | — | $1,976,000 |
| Product And Service Other | $131,000 | $123,000 |